The Lilly Lecture 1976: Insulin, Glucagon, and Somatostatin in Normal Physiology and Diabetes Mellitus
The DOI matches its Crossref record.
Abstract
Studies are reviewed in which the roles of insulin and glucagon in normal physiology and in diabetes are examined. In normal man, glucose ingestion is accompanied by a rise in insulin and fall in glucagon and is primarily disposed of in the liver, an organ sensitive to both hormones. However, infusions of glucagon in physiologic amounts indicate that insulin secretion rather than glucagon inhibition is the primary factor determining glucose disposal. Furthermore, minor elevations in blood glucose elicit increments in insulin concentration and inhibition of hepatic glucose output in the absence of changes in plasma glucagon. The primary physiologic role of glucagon is to prevent the hypoglycemia that would otherwise accompany noncarbohydrate (protein)-mediated insulin secretion. In diabetic as well as normal patients the stimulatory effect of glucagon on hepatic glucose production is evanescent. Increases in glucagon or changes in the I/G ratio can bring about deterioration in glucose tolerance or in diabetic control only so long as absolute insulin deficiency is present or pharmacologic elevations in glucagon are produced. After somatostatin administration, prolonged hypoinsulinemia in normal subjects is observed to result in fasting hyperglycemia in the absence of basal glucagon secretion. In diabetic patients the improvement in postprandial hyperglycemia produced by somatostatin can be accounted for by its inhibitory action on carbohydrate absorption in the gastrointestinal tract. It is concluded that insulin deficiency is the primary pathophysiologic disturbance in diabetes. While glocagon may worsen the consequences of insulin lack, it is neither sufficient nor necessary for the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
“Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine Pancreas
Ganda, O. P., Weir, G. C., Soeldner, J. S., Legg, M. A., Chick, W. L., Patel, Y. C., Ebeid, A. M., Gabbay, K. H., & Reichlin, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704282961703 · Cited by 290
Synergistic Interactions of Physiologic Increments of Glucagon, Epinephrine, and Cortisol in the Dog
Eigler, N., Saccà, L., & Sherwin, R. S. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109264 · Cited by 260
Self-citationDiabetic ketoacidosis: new concepts and trends in pathogenesis and treatment
KREISBERG, R. A. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-5-681 · Cited by 179
Karakelides, H., Asmann, Y. W., Bigelow, M. L., Short, K. R., Dhatariya, K., Coenen-Schimke, J., Kahl, J., Mukhopadhyay, D., & Nair, K. S. (2007) · Diabetes · doi:10.2337/db07-0378 · Cited by 123
Pancreatic glucagon: Possible implications of the hyperglycemic hormone in diabetes control
Gossain, V. V., & Rovner, D. R. (1982) · Postgraduate Medicine · doi:10.1080/00325481.1982.11716122 · Cited by 2
Metadata
- Authors
- Felig, P., Wahren, J., Sherwin, R., & Hendler, R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1976-12-01
- Volume
- 25
- Issue
- 12
- Pages
- 1091-1099
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2140250006
- Cited by
- 109
- References
- 0
- FWCI
- 24.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Lilly Lecture 1976: Insulin, Glucagon, and Somatostatin in Normal Physiology and Diabetes Mellitus. https://app.cochat.ai/papers/10.2337/diab.25.12.1091
- The paper
- Felig, P., Wahren, J., Sherwin, R., & Hendler, R. (1976). The Lilly Lecture 1976: Insulin, Glucagon, and Somatostatin in Normal Physiology and Diabetes Mellitus. Diabetes. https://doi.org/10.2337/diab.25.12.1091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.